BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15194373)

  • 1. Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation?
    Stratta RJ; Alloway RR; Lo A; Hodge EE;
    Transplant Proc; 2004 May; 36(4):1076-7. PubMed ID: 15194373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.
    Stratta RJ; Shokouh-Amiri MH; Egidi MF; Grewal HP; Lo A; Kizilisik AT; Nezakatgoo N; Gaber LW; Gaber AO
    Clin Transplant; 2003; 17 Suppl 9():69-77. PubMed ID: 12795673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
    Stratta RJ; Alloway RR; Hodge E; Lo A;
    Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Bruce DS; Sollinger HW; Humar A; Sutherland DE; Light JA; Kaufman DB; Alloway RR; Lo A; Stratta RJ
    Transplantation; 2001 Nov; 72(10):1637-43. PubMed ID: 11726823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage.
    Kaufman DB; Leventhal JR; Koffron A; Gheorghiade M; Elliott MD; Parker MA; Abecassis MM; Fryer JP; Stuart FP
    Surgery; 2000 Oct; 128(4):726-37. PubMed ID: 11015108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
    Stratta RJ; Alloway RR; Lo A; Hodge E
    Transplantation; 2003 Apr; 75(8):1260-6. PubMed ID: 12717213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years.
    Stratta RJ; Alloway RR; Lo A; Hodge EE
    Transplant Proc; 2005 Oct; 37(8):3531-4. PubMed ID: 16298651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage.
    Lo A; Stratta RJ; Hathaway DK; Egidi MF; Shokouh-Amiri MH; Grewal HP; Winsett R; Trofe J; Alloway RR; Gaber AO
    Am J Kidney Dis; 2001 Jul; 38(1):132-43. PubMed ID: 11431193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression.
    Stratta RJ; Lo A; Shokouh-Amiri MH; Egidi MF; Gaber LW; Gaber AO
    Transpl Int; 2003 Mar; 16(3):154-60. PubMed ID: 12664209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No induction versus anti-IL2R induction therapy in simultaneous kidney pancreas transplantation: a comparative analysis.
    Becker LE; Nogueira VA; Abensur H; Miranda MP; Genzini T; Romão JE; Noronha IL
    Transplant Proc; 2006; 38(6):1933-6. PubMed ID: 16908327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber LW; Gaber AO
    Transpl Int; 2001 Dec; 14(6):396-404. PubMed ID: 11793037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction.
    Stratta RJ; Gaber AO; Shokouh-Amiri MH; Reddy KS; Alloway RR; Egidi MF; Grewal HP; Gaber LW; Hathaway D
    Ann Surg; 1999 May; 229(5):701-8; discussion 709-12. PubMed ID: 10235529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Hodge EE;
    Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ; Alloway RR; Lo A; Hodge EE
    Transplant Proc; 2005 Oct; 37(8):3527-30. PubMed ID: 16298650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 9-year experience with 126 pancreas transplants with portal enteric drainage.
    Stratta RJ; Gaber AO; Shokouh-Amiri MH; Grewal HP; Egidi MF; Kizilisik AT; Hathaway DK; Gaber LW
    Arch Surg; 2001 Oct; 136(10):1141-9. PubMed ID: 11585506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
    Stratta RJ; Alloway RR; Lo A; Hodge EE;
    Transplant Proc; 2004 May; 36(4):1080-1. PubMed ID: 15194375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
    Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
    Reddy KS; Stratta RJ; Shokouh-Amiri H; Alloway R; Somerville T; Egidi MF; Gaber LW; Gaber AO
    Transplantation; 2000 Jan; 69(1):49-54. PubMed ID: 10653379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.